JMB-HEADER NAUKA RAS RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2014  0,718
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 51(2017) N 4 p. 514-525; DOI 10.1134/S0026893317040033 Full Text

A.V. Bannikov1*, A.V. Lavrov1,2

CRISPR/CAS9, the King of Genome Editing Tools

1Medical Genetic Research Center, Moscow, 115478 Russia
2Pirogov Russian National Research Medical University, Moscow, 117997 Russia

*broyler3@mail.ru
Received - 2016-06-15; Accepted - 2016-10-27

The discovery of CRISPR/Cas9 brought a hope for having an efficient, reliable, and readily available tool for genome editing. CRISPR/Cas9 is certainly easy to use, while its efficiency and reliability remain the focus of studies. The review describes the general principles of the organization and function of Cas nucleases and a number of important issues to be considered while planning genome editing experiments with CRISPR/Cas9. The issues include evaluation of the efficiency and specificity for Cas9, sgRNA selection, Cas9 variants designed artificially, and use of homologous recombination and nonhomologous end joining in DNA editing.

CRISPR/Cas9, genome editing, sgRNA



JMB-FOOTER RAS-JOURNALS